Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro

Yosei Kawamata, Yuji Nagayama, Kazuhiko Nakao, Hiroyuki Mizuguchi, Takao Hayakawa, Toshinori Sato, Nobuko Ishii

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Recombinant adenovirus is one of the most widely used viral vectors for gene delivery. This study was designed to evaluate the ability of chitosan, a cationic, linear polysaccharide composed of β(1,4) linked glucosamine partly containing N-acetyl-glucosamine, to enhance the in vitro infectivity of adenovirus to mammalian cells. Wild type and a fiber-mutant replication-defective recombinant adenoviruses expressing β-galactosidase were used. In the latter, an RGD peptide, the binding site for αvβ3 and αvβ5 integrin, was introduced in the fiber knob enabling adenovirus receptor-independent viral infection. Enhanced effect of chitosan on the infectivity of both adenoviruses was observed in Chinese hamster ovary cells that do not express the receptor for adenovirus with β-galactosidase activity assay and x-gal staining. These data indicate the receptor-independent mechanism(s) for this enhancement effect. In addition, we found that pH of the culture medium, and molecular mass and concentration of chitosan are also critical factors. Thus, the highest effect was obtained with 0.1-1μg/ml of chitosan with molecular mass of 19K and 40K in the culture medium of pH 6.4; on the other hand, the effect was negligible with the higher chitosan concentrations (10μg/ml or more), lower or higher molecular mass (11K and 110K) of chitosan, or at pH of 7.4. Studies using several cell lines with variable levels of adenoviral infectivity revealed that this enhanced effect is evident in the cells with poor infectivity to adenovirus. Since chitosan is biocompatible and inexpensive, these data indicate that chitosan may be a potential candidate for a non-viral vector to safely increase adenoviral infectivity to mammalian cells, particularly those with poor susceptibility to adenoviral infection.

Original languageEnglish
Pages (from-to)4573-4579
Number of pages7
JournalBiomaterials
Volume23
Issue number23
DOIs
Publication statusPublished - 2002 Dec

Fingerprint

Gene transfer
Chitosan
Adenoviridae
Genes
Molecular mass
Cells
Galactosidases
Glucosamine
Culture Media
Knobs
Viral Genes
In Vitro Techniques
Fibers
Virus Diseases
Binding sites
Polysaccharides
Cricetulus
Integrins
Peptides
Ovary

Keywords

  • Adenovirus
  • Chitosan
  • CHO cells
  • Gene transfer
  • Integrin

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Kawamata, Y., Nagayama, Y., Nakao, K., Mizuguchi, H., Hayakawa, T., Sato, T., & Ishii, N. (2002). Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro. Biomaterials, 23(23), 4573-4579. https://doi.org/10.1016/S0142-9612(02)00203-X

Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro. / Kawamata, Yosei; Nagayama, Yuji; Nakao, Kazuhiko; Mizuguchi, Hiroyuki; Hayakawa, Takao; Sato, Toshinori; Ishii, Nobuko.

In: Biomaterials, Vol. 23, No. 23, 12.2002, p. 4573-4579.

Research output: Contribution to journalArticle

Kawamata, Y, Nagayama, Y, Nakao, K, Mizuguchi, H, Hayakawa, T, Sato, T & Ishii, N 2002, 'Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro', Biomaterials, vol. 23, no. 23, pp. 4573-4579. https://doi.org/10.1016/S0142-9612(02)00203-X
Kawamata, Yosei ; Nagayama, Yuji ; Nakao, Kazuhiko ; Mizuguchi, Hiroyuki ; Hayakawa, Takao ; Sato, Toshinori ; Ishii, Nobuko. / Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro. In: Biomaterials. 2002 ; Vol. 23, No. 23. pp. 4573-4579.
@article{0d90dc15c6fb4315bec7e1524bcadfaf,
title = "Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro",
abstract = "Recombinant adenovirus is one of the most widely used viral vectors for gene delivery. This study was designed to evaluate the ability of chitosan, a cationic, linear polysaccharide composed of β(1,4) linked glucosamine partly containing N-acetyl-glucosamine, to enhance the in vitro infectivity of adenovirus to mammalian cells. Wild type and a fiber-mutant replication-defective recombinant adenoviruses expressing β-galactosidase were used. In the latter, an RGD peptide, the binding site for αvβ3 and αvβ5 integrin, was introduced in the fiber knob enabling adenovirus receptor-independent viral infection. Enhanced effect of chitosan on the infectivity of both adenoviruses was observed in Chinese hamster ovary cells that do not express the receptor for adenovirus with β-galactosidase activity assay and x-gal staining. These data indicate the receptor-independent mechanism(s) for this enhancement effect. In addition, we found that pH of the culture medium, and molecular mass and concentration of chitosan are also critical factors. Thus, the highest effect was obtained with 0.1-1μg/ml of chitosan with molecular mass of 19K and 40K in the culture medium of pH 6.4; on the other hand, the effect was negligible with the higher chitosan concentrations (10μg/ml or more), lower or higher molecular mass (11K and 110K) of chitosan, or at pH of 7.4. Studies using several cell lines with variable levels of adenoviral infectivity revealed that this enhanced effect is evident in the cells with poor infectivity to adenovirus. Since chitosan is biocompatible and inexpensive, these data indicate that chitosan may be a potential candidate for a non-viral vector to safely increase adenoviral infectivity to mammalian cells, particularly those with poor susceptibility to adenoviral infection.",
keywords = "Adenovirus, Chitosan, CHO cells, Gene transfer, Integrin",
author = "Yosei Kawamata and Yuji Nagayama and Kazuhiko Nakao and Hiroyuki Mizuguchi and Takao Hayakawa and Toshinori Sato and Nobuko Ishii",
year = "2002",
month = "12",
doi = "10.1016/S0142-9612(02)00203-X",
language = "English",
volume = "23",
pages = "4573--4579",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "23",

}

TY - JOUR

T1 - Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro

AU - Kawamata, Yosei

AU - Nagayama, Yuji

AU - Nakao, Kazuhiko

AU - Mizuguchi, Hiroyuki

AU - Hayakawa, Takao

AU - Sato, Toshinori

AU - Ishii, Nobuko

PY - 2002/12

Y1 - 2002/12

N2 - Recombinant adenovirus is one of the most widely used viral vectors for gene delivery. This study was designed to evaluate the ability of chitosan, a cationic, linear polysaccharide composed of β(1,4) linked glucosamine partly containing N-acetyl-glucosamine, to enhance the in vitro infectivity of adenovirus to mammalian cells. Wild type and a fiber-mutant replication-defective recombinant adenoviruses expressing β-galactosidase were used. In the latter, an RGD peptide, the binding site for αvβ3 and αvβ5 integrin, was introduced in the fiber knob enabling adenovirus receptor-independent viral infection. Enhanced effect of chitosan on the infectivity of both adenoviruses was observed in Chinese hamster ovary cells that do not express the receptor for adenovirus with β-galactosidase activity assay and x-gal staining. These data indicate the receptor-independent mechanism(s) for this enhancement effect. In addition, we found that pH of the culture medium, and molecular mass and concentration of chitosan are also critical factors. Thus, the highest effect was obtained with 0.1-1μg/ml of chitosan with molecular mass of 19K and 40K in the culture medium of pH 6.4; on the other hand, the effect was negligible with the higher chitosan concentrations (10μg/ml or more), lower or higher molecular mass (11K and 110K) of chitosan, or at pH of 7.4. Studies using several cell lines with variable levels of adenoviral infectivity revealed that this enhanced effect is evident in the cells with poor infectivity to adenovirus. Since chitosan is biocompatible and inexpensive, these data indicate that chitosan may be a potential candidate for a non-viral vector to safely increase adenoviral infectivity to mammalian cells, particularly those with poor susceptibility to adenoviral infection.

AB - Recombinant adenovirus is one of the most widely used viral vectors for gene delivery. This study was designed to evaluate the ability of chitosan, a cationic, linear polysaccharide composed of β(1,4) linked glucosamine partly containing N-acetyl-glucosamine, to enhance the in vitro infectivity of adenovirus to mammalian cells. Wild type and a fiber-mutant replication-defective recombinant adenoviruses expressing β-galactosidase were used. In the latter, an RGD peptide, the binding site for αvβ3 and αvβ5 integrin, was introduced in the fiber knob enabling adenovirus receptor-independent viral infection. Enhanced effect of chitosan on the infectivity of both adenoviruses was observed in Chinese hamster ovary cells that do not express the receptor for adenovirus with β-galactosidase activity assay and x-gal staining. These data indicate the receptor-independent mechanism(s) for this enhancement effect. In addition, we found that pH of the culture medium, and molecular mass and concentration of chitosan are also critical factors. Thus, the highest effect was obtained with 0.1-1μg/ml of chitosan with molecular mass of 19K and 40K in the culture medium of pH 6.4; on the other hand, the effect was negligible with the higher chitosan concentrations (10μg/ml or more), lower or higher molecular mass (11K and 110K) of chitosan, or at pH of 7.4. Studies using several cell lines with variable levels of adenoviral infectivity revealed that this enhanced effect is evident in the cells with poor infectivity to adenovirus. Since chitosan is biocompatible and inexpensive, these data indicate that chitosan may be a potential candidate for a non-viral vector to safely increase adenoviral infectivity to mammalian cells, particularly those with poor susceptibility to adenoviral infection.

KW - Adenovirus

KW - Chitosan

KW - CHO cells

KW - Gene transfer

KW - Integrin

UR - http://www.scopus.com/inward/record.url?scp=0346003766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346003766&partnerID=8YFLogxK

U2 - 10.1016/S0142-9612(02)00203-X

DO - 10.1016/S0142-9612(02)00203-X

M3 - Article

VL - 23

SP - 4573

EP - 4579

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 23

ER -